Abstract
There is potential for mobile applications to deliver new self-management interventions for chronic disease, especially in diabetes. The aim of the present study was to evaluate the effects of a mobile phone application (MPA) combined with or without self-monitoring of blood glucose (SMBG) on glycemic control in patients with diabetes. The study was a 24-week period, four-arm parallel group, non-blinded, randomized trial. A total of 185 patients with mean age of 52 years were randomized to group A (no MPA and no SMBG), group B (SMBG only), group C (MPA only) and group D (both MPA and SMBG were used). Changes in glycated hemoglobin (HbA1c), fasting plasma glucose and 1,5-anhydroglucitol from baseline to week 24 were analyzed. At 24 weeks, the HbA1c levels in patients of all groups decreased significantly from baseline. There were significant differences in the proportions of patients that achieved HbA1c <7% between groups, especially in group C and group D, compared with group A at week 24 (60.4%, 62.2% vs 25.5%, all P < 0.05). 1,5-Anhydroglucitol changes were obvious in group A and group C at week 24 from baseline (all P < 0.05 within groups). Factorial analysis of anova showed that MPA intervention was the main effective facto...Continue Reading
References
May 14, 2008·Diabetes Technology & Therapeutics·Charlene C QuinnAnn Gruber-Baldini
Feb 27, 2013·Journal of Diabetes Science and Technology·Omar El-GayarWael Eid
Sep 5, 2013·JAMA : the Journal of the American Medical Association·Yu XuUNKNOWN 2010 China Noncommunicable Disease Surveillance Group
Nov 15, 2013·Journal of Medical Internet Research·Morwenna KirwanMitch J Duncan
Feb 5, 2014·Health Affairs·Shantanu NundyMonica E Peek
Feb 8, 2014·Diabetes Technology & Therapeutics·Nazar S HaddadJohn W Gregory
Mar 19, 2014·Diabetes Research and Clinical Practice·L GuariguataJ E Shaw
Apr 3, 2014·Heart and Vessels·Takayuki FujiwaraJunya Ako
May 31, 2014·Journal of Diabetes Science and Technology·Charlene C QuinnAnn L Gruber-Baldini
Jul 22, 2014·Diabetes Research and Clinical Practice·Tania TomaHutan Ashrafian
Feb 19, 2015·Diabetes Technology & Therapeutics·Charlene C QuinnAnn L Gruber-Baldini
Apr 15, 2015·Clinical Therapeutics·Bonnie KatalenichVivian Fonseca
Oct 24, 2015·Endocrine·Adriana CoppolaCarmine Gazzaruso
Jun 2, 2016·Endocrinology and Metabolism·Min Kyeong KimSeong Yeon Kim
Jun 21, 2016·Diabetes Research and Clinical Practice·Weibin ZhouYan Sun
Nov 20, 2016·PloS One·Mingxuan CuiMin Nie
Nov 30, 2016·Acta Diabetologica·Yao WangZilin Sun
Mar 16, 2017·MHealth·Mohammed M AlotaibiNada Philip
May 2, 2017·Indian Journal of Endocrinology and Metabolism·Shruti MuralidharanViswanathan Mohan
Jun 28, 2017·JAMA : the Journal of the American Medical Association·Limin WangLinhong Wang
Oct 24, 2017·Diabetic Medicine : a Journal of the British Diabetic Association·X HuW Jia
Dec 15, 2017·Therapeutic Advances in Endocrinology and Metabolism·Baris SaglamBanu Onvural
Mar 27, 2018·The Diabetes Educator·Shefali KumarJessie L Juusola
Jul 19, 2018·Clinica Chimica Acta; International Journal of Clinical Chemistry·Marciane WelterGeraldo Picheth
Sep 29, 2018·Journal of Diabetes Science and Technology·Kasun C GunawardenaDimuthu Muthukuda
Citations
Jun 3, 2020·Journal of Medical Internet Research·Dongjin SeoJae-Ho Lee
Jul 4, 2020·European Journal of Preventive Cardiology·Martijn ScherrenbergPaul Dendale
Jul 17, 2020·JMIR Diabetes·Laura KellyDavid Morley
Dec 10, 2019·Journal of Medical Internet Research·Lei ZhangYuqian Bao
Dec 4, 2019·Diabetology & Metabolic Syndrome·Betsabe Contreras-HaroJorge I Gamez-Nava
Feb 16, 2021·JMIR MHealth and UHealth·Claudia EberleStefanie Stichling
Feb 22, 2021·European Journal of Preventive Cardiology·Martijn ScherrenbergPaul Dendale
May 14, 2021·Current Atherosclerosis Reports·Maan Isabella CajitaLora E Burke